Dimensional Fund Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44.6M | Sell |
917,712
-19,433
| -2% | -$945K | 0.01% | 1564 |
|
|
2025
Q1 | $31.9M | Sell |
937,145
-10,156
| -1% | -$346K | 0.01% | 1715 |
|
|
2024
Q4 | $37.3M | Buy |
947,301
+122,695
| +15% | +$4.83M | 0.01% | 1687 |
|
|
2024
Q3 | $38.7M | Sell |
824,606
-125,543
| -13% | -$5.9M | 0.01% | 1656 |
|
|
2024
Q2 | $51.3M | Buy |
950,149
+19,094
| +2% | +$1.03M | 0.01% | 1452 |
|
|
2024
Q1 | $63.5M | Buy |
931,055
+151,601
| +19% | +$10.3M | 0.02% | 1293 |
|
|
2023
Q4 | $48.8M | Sell |
779,454
-100,347
| -11% | -$6.28M | 0.01% | 1464 |
|
|
2023
Q3 | $39.9M | Buy |
879,801
+168,530
| +24% | +$7.65M | 0.01% | 1494 |
|
|
2023
Q2 | $39.9M | Sell |
711,271
-48,464
| -6% | -$2.72M | 0.01% | 1509 |
|
|
2023
Q1 | $34.4M | Sell |
759,735
-15,076
| -2% | -$682K | 0.01% | 1604 |
|
|
2022
Q4 | $31.5K | Buy |
774,811
+125,751
| +19% | +$5.11K | 0.01% | 1622 |
|
|
2022
Q3 | $42.4M | Buy |
649,060
+209,134
| +48% | +$13.7M | 0.02% | 1363 |
|
|
2022
Q2 | $26.7M | Buy |
439,926
+199,939
| +83% | +$12.2M | 0.01% | 1698 |
|
|
2022
Q1 | $15.1M | Sell |
239,987
-19,054
| -7% | -$1.2M | ﹤0.01% | 2120 |
|
|
2021
Q4 | $19.6M | Buy |
259,041
+104,371
| +67% | +$7.91M | 0.01% | 1998 |
|
|
2021
Q3 | $17.3M | Buy |
154,670
+8,848
| +6% | +$990K | 0.01% | 2073 |
|
|
2021
Q2 | $23.6M | Buy |
145,822
+7,072
| +5% | +$1.14M | 0.01% | 1974 |
|
|
2021
Q1 | $16.9M | Buy |
138,750
+31,103
| +29% | +$3.79M | 0.01% | 2091 |
|
|
2020
Q4 | $16.5M | Buy |
107,647
+5,990
| +6% | +$918K | 0.01% | 2071 |
|
|
2020
Q3 | $8.51M | Buy |
101,657
+645
| +0.6% | +$54K | ﹤0.01% | 2268 |
|
|
2020
Q2 | $7.43M | Buy |
101,012
+12,527
| +14% | +$921K | ﹤0.01% | 2319 |
|
|
2020
Q1 | $3.75M | Buy |
88,485
+41,952
| +90% | +$1.78M | ﹤0.01% | 2517 |
|
|
2019
Q4 | $2.83M | Buy |
+46,533
| New | +$2.83M | ﹤0.01% | 2767 |
|